During the past decade, Valko and Associates conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Valko and Associates" #1 collaborator was "Pfizer" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Valko and Associates" are "Down Syndrome" (2 trials). Many other conditions were trialed in "Valko and Associates" in a lesser frequency.

Most popular intervention types in "Valko and Associates" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Donepezil HCl" (1 trials), "Donepezil hydrochloride (Aricept)" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Valko and Associates" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Valko and Associates". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Valko and Associates, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Valko and Associates, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".